We aspire to keep the wonderful world visible for all
navigate_nextAbout us
Revenio is a global leader in ophthalmological devices. Revenio Group's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters. The main tools for the detection and diagnosis of glaucoma and its monitoring during treatment are intraocular pressure measurement (tonometry), retinal imaging, and visual field tests (perimetry).
In 2019, the Group's net sales totaled EUR 61.1 million, with its operating profit standing at 28.1%. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.
Annual Report 2020
Revenio has published its Annual Report for 2020
Upcoming event
Q1 interim report will be published on April 23, 2021
IR contacts
CFO Robin Pulkkinen robin.pulkkinen(at)revenio.fi
Share price {{stockPriceLatestDate}}: {{stockPrice}} {{currency}}
Revenio is listed on Nasdaq Helsinki
Analyses
Revenio is followed by Carnegie, Inderes, OP and SEB
Revenio Group Oyj | Äyritie 22 | 01510 Vantaa